author-photo

Xinglong Liu

Guangzhou Institutes of Biomedicine and Health

11

Papers

180

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.

2021 Emerging microbes & infections
Show All
- Source
- Cite
- Save
Citations (2)
A Live-attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice

2021 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (0)
Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fcγ Receptor-Dependent and -Independent Pathways.

2021 Mbio
Show All
- Source
- Cite
- Save
Citations (4)
Human desmoglein-2 and human CD46 mediate HAdV55 infection but human desmoglein-2 plays the major roles.

2020 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (2)
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques.

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (84)
Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model

2019 Emerging microbes & infections
Show All
- Source
- Cite
- Save
Citations (15)
Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity

2018 Virology
Show All
- Source
- Cite
- Save
Citations (10)